Orthofix names 3 independent directors

Orthofix named three independent directors to its board, the devicemaker said Dec. 12.

Advertisement

The directors are Alan Bazaar, CEO of wealth management firm Hollow Brook Wealth Management; Michael Finegan, CEO of Acera Surgical, and Charles Kummeth, president and CEO of Bio-Techne Corporation, according to a news release.

The appointments come after Orthofix entered a cooperation agreement with Engine Capital Management, one of the company’s shareholders.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.